Joey Lau Börjesson 3D bioprints human pancreatic islets in PAN X and evaluates their function.
Casper F.T. van der Ven uses the INKREDIBLE+ to model calcific aortic valve disease.
A. Pössl’s work on cell therapy treatment of diabetes mellitus, highlights the interplay between bioink, cell culture and 3D printer.
T. Hananouchi examines the mechanical properties of three different bioinks printed with the INKREDIBLE.
PhD student Thomas Richardson evaluates the Perriman Group bioink at CELLINK’s Gothenburg headquarters.
Professor Cristina Scielzo 3D bioprint leukemic cells using the CELLINK Laminink series.